Acino links with Berlin Pharma to market range of products in Thailand

Thailand-based Berlin Pharmaceutical Industry and Acino Pharma AG (SIX: ACIN) have signed a long term partnership agreement under which the former will market a wide range of the Swiss company's current and future products in Thailand. Under Thai regulations, the drugs in question cannot be identified at this stage.

"The new products will complement our current line of therapies as well as significantly expand our presence into new areas," said Amal Naj, chief executive of Berlin, adding "We are very excited about this association with Acino and the high quality products we will bring to our patients at affordable prices," he said.

Peter Burema, CEO of Acino Group, said: "We are very pleased to partner with one of the leading pharmaceutical companies in Thailand to introduce our products in the market. We see great opportunities for our products there and rest of Asia and other emerging markets."